Lv11
50 积分 2023-02-23 加入
110P Safety and effectiveness of adebrelimab as first-line treatment in extensive-stage small-cell lung cancer: A prospective, real-world study
43分钟前
已关闭
Therapy of small cell lung cancer: a perspective on two decades of clinical research
2小时前
已关闭
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
3个月前
已完结
Stressed-out T Cells Linked to Resistance
5个月前
已完结
Facts and hopes on cancer immunotherapy for small cell lung cancer
7个月前
已完结
Stressed-out T Cells Linked to Resistance
8个月前
已完结
OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial
8个月前
已完结
LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)
8个月前
已关闭
Phase I/II combination study of tifcemalimab with toripalimab in patients with refractory extensive stage small cell lung cancer (ES-SCLC)
8个月前
已完结
皖公网安备34019202002308
